The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Impax International Sust Econ Inv PXINX
- NAV / 1-Day Return 10.50 / +1.37 %
- Total Assets 1.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.720%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.99%
- Turnover 56%
USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:17 PM GMT+0
Morningstar’s Analysis PXINX
Will PXINX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
ASML Holding NV | 3.61 | 40.9 Mil | Technology |
Novo Nordisk A/S Class B | 2.78 | 31.5 Mil | Healthcare |
Novartis AG Registered Shares | 2.60 | 29.5 Mil | Healthcare |
AstraZeneca PLC | 2.42 | 27.4 Mil | Healthcare |
HSBC Holdings PLC | 2.25 | 25.4 Mil | Financial Services |
Schneider Electric SE | 2.07 | 23.4 Mil | Industrials |
Tokio Marine Holdings Inc | 1.89 | 21.4 Mil | Financial Services |
SoftBank Corp | 1.85 | 21.0 Mil | Communication Services |
Jpmorgan Chase Var 12/49 | 1.84 | 20.9 Mil | — |
BNP Paribas Act. Cat.A | 1.81 | 20.6 Mil | Financial Services |